On January 27, 2021, Sire Bioscience Inc. (CNSX:SIRE) closed the transaction. The transaction included participation from Brian Polla, Chief Executive Officer, Chief Operating Officer and a director of the company for 4,600,000 shares for CAD 230,000, Domenic Crudo, Chief Financial Officer and Secretary of the company for 200,000 shares for CAD 10,000 personally and 800,000 shares for CAD 40,000 through his company 1610896 Ontario Inc., and Brian Nugent, a director of the company for 300,000 shares for CAD 15,000. The company did not pay any finders fees in the transaction. The company has received $11,741(CAD 14,999.36232) pursuant to exemption provided under Regulation D from a single investor.